Oropharyngeal gonorrhoea: Rate of co-infection with sexually transmitted infection, antibiotic susceptibility and treatment outcome

International Journal of STD and AIDS

Volumn 21, Issue 2, 2010, Pages 138-140

  Manavi, K ^a   Zafar, F ^a   Shahid, H ^a  

^a Whittall Street Clinic ^*  (United Kingdom)

Author keywords

Antibiotic susceptibility; Cefixime; Co infection; Oropharyngeal gonorrhoea

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; PENICILLIN G; SPECTINOMYCIN; TETRACYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHLAMYDIASIS; FEMALE; GONORRHEA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OROPHARYNX; PATIENT COUNSELING; PRIORITY JOURNAL; RECTUM; RETROSPECTIVE STUDY; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; COMORBIDITY; DRUG RESISTANCE, BACTERIAL; FEMALE; GONORRHEA; GREAT BRITAIN; HUMANS; MALE; MEDICAL AUDIT; MOUTH DISEASES; NEISSERIA GONORRHOEAE; PHARYNGEAL DISEASES; RECTAL DISEASES; RETROSPECTIVE STUDIES; SEXUALLY TRANSMITTED DISEASES; TREATMENT OUTCOME;

EID: 75449110249     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009167     Document Type: Article

References (11)

1. Health Protection Agency. All new STI episodes made at genitourinary medicine (GUM) clinics in the United Kingdom: 1998-2007. See http://www.hpa.org.uk/web/HPAweb&Page&HPAwebAutoListName/Page/ 1201094610372 (last accessed April 2009)
2. McMillan A, Young H. Gonorrhoea in the homosexual man: frequency of infection by culture site. Sex Transm Dis 1978;5:146-50
3. Moran JS. Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomical site of infection important?. Sex Transm Dis 1995;22:39-47
4. Clinical Effectiveness Group. BASHH. National Guideline on the Diagnosis and Treatment of Gonorrhoea in Adults 2005. See http://www.bashh.org/documents/ 116/116.pdf (last accessed April 2009)
5. Bro-Jorgensen A, Jensen T. Gonococcal pharyngeal infections. Report of 110 cases. Br J Vener Dis 1973;49:491-9
6. Sherrard J, Barlow D. Gonorrhoea in men. Lancet 1993;341:245
7. Grasp Steering Group. GRASP: The Gonococcal Resistance to Antimicrobials Surveillance Programme. Annual Report 2007. See http://www.hpa.org.uk/web/ HPAwebFile/HPAweb-C/1221117895841 (last accessed April 2009)
8. McMillan A, Young H. The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime. Int J STD AIDS 2007;18:253-4
9. Sathia L, Ellis B, Philip S, Winston A, Smith A. Pharyngeal gonorrhoea - is dual therapy the way forward? Int J STD AIDS 2007;18:647-54
10. Stolz E, Ong L, van Joost T, Michel M. Treatment of non-complicated urogenital, rectal and oropharyngeal gonorrhoea with intramuscular cefotaxime 1.0 g or cefuroxime 1.5 g. J Antimicrob Chemother 1984;14(suppl. B):295-9
11. Manavi K, Young H, McMillan A. The outcome of oropharyngeal gonorrhoea treatment with different regimens. Int J STD AIDS 2005;16:68-70